基于脂质组学探究散寒化湿方治疗呼吸道合胞病毒肺炎模型小鼠的作用机制

Lipidomics-Based Study on the Mechanism of Sanhan Huashi Formula in Treating Respiratory Syncytial Virus Pneumonia Model Mice

  • 摘要:
    目的 研究散寒化湿方对呼吸道合胞病毒(RSV)感染小鼠模型的治疗作用,并结合脂质组学探讨其潜在的抗病毒及抗炎机制。
    方法 将54只BALB/c小鼠随机分为空白组、模型组、利巴韦林(50 mg·kg-1·d-1)组及SHF高(散寒化湿方15.46 g·kg-1·d-1)、SHF中(散寒化湿方7.73 g·kg-1·d-1)、SHF低(散寒化湿方3.87 g·kg-1·d-1)剂量组,每组9只。通过滴鼻感染RSV建立肺炎小鼠模型,各组小鼠连续灌胃给药3 d。分别采集各组小鼠肺组织样本,通过HE染色法及炎症评分评估各组小鼠的肺组织病理学变化;RT-qPCR法检测病毒融合蛋白(F)、糖蛋白(G)和炎症因子肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)的mRNA表达水平以评估肺部病毒载量和炎症水平,同时免疫荧光染色观察RSV-F在肺组织中的表达;应用超高效液相色谱-四极杆-静电场轨道阱高分辨质谱法(UPLC-Q Exactive Orbitrap MS)研究RSV感染小鼠的血清脂质组学变化。
    结果 与空白组相比,模型组小鼠肺部出现明显炎症细胞浸润与组织损伤,肺组织病理评分及肺指数明显升高,肺组织病毒载量及肺部炎症因子TNF-α、IL-6 mRNA水平表达显著增加,免疫荧光结果亦提示RSV-F在肺组织中高表达;与模型组比较,散寒化湿方治疗可明显改善肺组织损伤,并有效抑制病毒基因表达及炎症因子水平,同时减弱RSV-F在肺组织中的荧光信号强度。脂质组学研究显示,与空白组相比,模型组呈现明显脂质代谢异常,主要表现为甘油三酯(TG)、磷脂酰胆碱(PC)、溶血磷脂酰胆碱(LPC)、鞘磷脂(SM)、二酰甘油(DG)、溶血磷脂酰乙醇胺(LPE)和磷脂酰乙醇胺(PE)等脂质代谢紊乱,散寒化湿方高剂量治疗可以调节RSV感染引发的上述脂质紊乱。
    结论 散寒化湿方能有效改善RSV感染引起的肺部炎症及病理损伤,降低肺部RSV病毒载量,可能与调节外周血脂质代谢紊乱有关。

     

    Abstract:
    OBJECTIVE To investigate the therapeutic effect of Sanhan Huashi Formula (SHF) on respiratory syncytial virus (RSV)-infected mouse models and explore its potential antiviral and anti-inflammatory mechanisms using lipidomics.
    METHODS Fifty-four BALB/c mice were randomly divided into six groups (n=9): blank group, model group, Ribavirin group (50 mg·kg-1·d-1), and SHF high (15.46 g·kg-1·d-1), medium (7.73 g·kg-1·d-1), and low-dose (3.87 g·kg-1·d-1) groups. A pneumonia model was established by intranasal RSV infection, followed by three consecutive days of oral gavage administration. Lung tissues were collected for histopathological evaluation using hematoxylin-eosin (HE) staining and inflammation scoring. Real-time quantitative polymerase chain reaction (RT-qPCR) was performed to measure mRNA levels of viral gene fusion protein (F), glycoprotein (G), and inflammatory factors tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) to assess lung viral load and inflammation, while immunofluorescence staining was performed to observe the expression of RSV-F protein in lung tissues. Serum lipidomics analysis was conducted using ultra-performance liquid chromatography-quadrupole-electrostatic field orbitrap high-resolution mass spectrometry (UPLC-Q Exactive Orbitrap MS) to identify lipid metabolism changes and differential lipids.
    RESULTS Compared with the blank group, mice in the model group exhibited marked pulmonary inflammatory cell infiltration and tissue injury, with significantly elevated pulmonary histopathology scores and lung index. The lung viral load and the mRNA expression levels of the inflammatory factors TNF-α and IL-6 were significantly increased, and immunofluorescence likewise indicated high expression of RSV-F protein in lung tissue. Relative to the model group, treatment with SHF at all tested doses clearly ameliorated lung tissue injury, effectively suppressed viral gene expression and inflammatory cytokine levels, and reduced the fluorescence signal intensity of RSV-F protein in the lungs. Lipidomics analysis revealed that compared with the blank group, the model group exhibited marked disturbances in lipid metabolism- characterized by dysregulation of triacylglycerol (TG), phosphatidylcholine (PC), lysophosphatidylcholine (LPC), sphingomyelin (SM), diacylglycerol (DG), lysophosphatidylethanolamine (LPE), and phosphatidylethanolamine (PE). High-dose SHF treatment reversed these RSV-induced lipid abnormalities.
    CONCLUSION SHF effectively alleviates RSV-induced pulmonary inflammation and pathological injury, reduces pulmonary RSV viral load, and may exert these effects by modulating dysregulated lipid metabolism in peripheral blood.

     

/

返回文章
返回